首页> 美国卫生研究院文献>Molecular Brain >Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI
【2h】

Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI

机译:TBI后神经元线粒体1型大麻素受体的急性上调及其在代谢缺陷和神经元凋亡中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Metabolic defects and neuronal apoptosis initiated by traumatic brain injury (TBI) contribute to subsequent neurodegeneration. They are all regulated by mechanisms centered around mitochondrion. Type-1 cannabinoid receptor (CB1) is a G-protein coupled receptor (GPCR) enriched on neuronal plasma membrane. Recent evidences point to the substantial presence of CB1 receptors on neuronal mitochondrial outer membranes (mtCB1) and the activation of mtCB1 influences aerobic respiration via inhibiting mitochondrial cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/complex I pathway. The expression and role of neuronal mtCB1 under TBI are unknown. Using TBI models of cultured neurons, wild type and CB1 knockout mice, we found mtCB1 quickly upregulated after TBI. Activation of mtCB1 promoted metabolic defects accompanied with ATP shortage but protected neurons from apoptosis. Selective activation of plasma membrane CB1 showed no effects on neuronal metabolism and apoptosis. Activation of mtCB1 receptors inhibited mitochondrial cAMP/PKA/complex I and resulted in exacerbated metabolic defects accompanied with a higher ratio of ATP reduction to oxygen consumption decrease as well as neuronal apoptosis. Further research found the remarkable accumulation of protein kinase B (AKT) on neuronal mitochondria following TBI and the activation of mtCB1 upregulated mitochondrial AKT/complex V activity. Upregulation of mitochondrial AKT/complex V activity showed anti-apoptosis effects and alleviated ATP shortage in metabolic defects. Taken together, we have identified mtCB1 quickly upregulate after TBI and a dual role the mtCB1 might play in metabolic defects and neuronal apoptosis initiated by TBI: the inhibition of mitochondrial cAMP/PKA/complex I aggravates metabolic defects, energy insufficiency as well as neuronal apoptosis, but the coactivation of mitochondrial AKT/complex V mitigates energy insufficiency and neuronal apoptosis.
机译:外伤性脑损伤(TBI)引发的代谢缺陷和神经元凋亡导致随后的神经变性。它们均由围绕线粒体的机制调节。 1型大麻素受体(CB1)是富集在神经元质膜上的G蛋白偶联受体(GPCR)。最近的证据表明,神经元线粒体外膜(mtCB1)上大量存在CB1受体,并且mtCB1的激活通过抑制线粒体环状单磷酸腺苷(cAMP)/蛋白激酶A(PKA)/复合I途径来影响有氧呼吸。 TBI下神经元mtCB1的表达和作用尚不清楚。使用培养的神经元,野生型和CB1基因敲除小鼠的TBI模型,我们发现mtCB1在TBI后迅速上调。 mtCB1的激活促进了伴随ATP缺乏的代谢缺陷,但保护了神经元免于凋亡。质膜CB1的选择性激活未显示对神经元代谢和凋亡的影响。 mtCB1受体的激活抑制线粒体cAMP / PKA /复合物I,并导致代谢缺陷加重,同时ATP减少与耗氧量减少以及神经元凋亡的比率更高。进一步的研究发现TBI后神经元线粒体中蛋白激酶B(AKT)的大量积累和mtCB1的激活上调了线粒体AKT /复合物V的活性。线粒体AKT /复合物V活性的上调显示抗凋亡作用并减轻了代谢缺陷中的ATP缺乏。综上所述,我们已经确定了TBI后mtCB1迅速上调,并且mtCB1可能在TBI引发的代谢缺陷和神经元凋亡中发挥双重作用:线粒体cAMP / PKA /复合物I的抑制加剧了代谢缺陷,能量不足和神经元凋亡,但线粒体AKT /复合物V的共激活可减轻能量不足和神经元凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号